Kingsview Wealth Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,119
Closed -$216K 979
2023
Q3
$216K Buy
3,119
+50
+2% +$3.78K 0.01% 856
2023
Q2
$248K Hold
3,069
0.01% 798
2023
Q1
$248K Hold
3,069
0.01% 775
2022
Q4
$230K Buy
+3,069
New +$219K 0.01% 749
2022
Q3
Sell
-3,069
Closed -$213K 848
2022
Q2
$213K Hold
3,069
0.01% 751
2022
Q1
$236K Hold
3,069
0.01% 768
2021
Q4
$235K Sell
3,069
-13
-0.4% -$956 0.01% 817
2021
Q3
$227K Hold
3,082
0.01% 768
2021
Q2
$210K Hold
3,082
0.01% 812
2021
Q1
$229K Buy
+3,082
New +$234K 0.01% 728

Other funds holding HOLX

Kingsview Wealth Management's HOLX Position: Q4 2023 in Review

Kingsview Wealth Management sold out of Hologic (HOLX) in Q4 2023, closing a stake of 3,119 shares — an estimated $216K sold.

Kingsview Wealth Management first reported a position in HOLX in Q1 2021 and held it in 10 quarters. The position peaked at $248K in Q2 2023. 733 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Kingsview Wealth Management reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Kingsview Wealth Management sold 3,119 Hologic shares in Q4 2023, an estimated $216K.
  • Kingsview Wealth Management first reported a position in Hologic in Q1 2021 and held it in 10 quarters.
  • Kingsview Wealth Management's Hologic position peaked at $248K in Q2 2023.
  • 733 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Kingsview Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.